LEMAITRE VASCULAR INC (LMAT)

↓ Download CSV

CIK 0001158895 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Fiscal year ends Dec 31

In fiscal 2025, LEMAITRE VASCULAR INC reported revenue of $249.60M, up 13.5% from the prior year. The company was profitable, with a net margin of 23.1% and a gross margin of 71.5%. It held $615.69M in total assets against $222.17M in total liabilities.

Key ratios (FY2025)

71.5%
Gross margin
27.2%
Operating margin
23.1%
Net margin
14.7%
Return on equity
+13.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$249.60M$219.86M$193.48M$161.65M$154.42M$129.37M$117.23M$105.57M$100.87M$89.15M
Cost of Revenue$71.06M$68.96M$66.44M$56.76M$53.04M$44.75M$37.38M$31.63M$30.17M$26.21M
Gross Profit$178.54M$150.90M$127.05M$104.90M$101.38M$84.62M$79.85M$73.94M$70.70M$62.94M
Operating Income$67.91M$52.26M$36.71M$26.83M$36.42M$28.79M$21.18M$28.21M$21.10M$16.34M
Net Income$57.73M$44.04M$30.11M$20.64M$26.91M$21.22M$17.93M$22.94M$17.18M$10.59M
EPS (Diluted)$2.52$1.93$1.34$0.93$1.25$1.04$0.88$1.13$0.86$0.55
Total Assets$615.69M$551.82M$346.78M$310.48M$292.80M$252.81M$188.34M$153.09M$126.32M$101.92M
Total Liabilities$222.17M$214.53M$48.88M$42.27M$38.65M$80.24M$40.20M$22.85M$16.55M$14.42M
Shareholders' Equity$393.52M$337.29M$297.90M$268.20M$254.15M$172.57M$148.14M$130.24M$109.77M$87.50M
Cash & Equivalents$28.24M$25.61M$24.27M$19.13M$13.86M$26.76M$11.79M$26.32M$19.10M$24.29M
Operating Cash Flow$81.25M$44.12M$36.75M$25.38M$35.10M$34.80M$14.18M$19.51M$22.87M$16.90M
Capital Expenditures$6.78M$6.96M$7.26M$3.23M$4.88M$2.98M$3.76M$3.05M$6.42M$2.84M
Shares Outstanding22.93M22.78M22.42M22.17M21.48M20.48M20.33M20.24M20.03M19.24M
Dividends Per Share$0.80$0.64$0.56$0.50$0.44$0.38$0.34$0.28$0.22$0.18